Does PEGASPARGASE Cause Secondary immunodeficiency? 217 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 217 reports of Secondary immunodeficiency have been filed in association with PEGASPARGASE (ONCASPAR). This represents 1.9% of all adverse event reports for PEGASPARGASE.
217
Reports of Secondary immunodeficiency with PEGASPARGASE
1.9%
of all PEGASPARGASE reports
215
Deaths
2
Hospitalizations
How Dangerous Is Secondary immunodeficiency From PEGASPARGASE?
Of the 217 reports, 215 (99.1%) resulted in death, 2 (0.9%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Secondary immunodeficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGASPARGASE. However, 217 reports have been filed with the FAERS database.
What Other Side Effects Does PEGASPARGASE Cause?
Febrile neutropenia (1,589)
Pyrexia (706)
Febrile bone marrow aplasia (668)
Sepsis (548)
Vomiting (530)
Neutropenia (521)
Abdominal pain (469)
Hypertriglyceridaemia (399)
Hypotension (388)
Thrombocytopenia (382)
What Other Drugs Cause Secondary immunodeficiency?
PREDNISONE (402)
CYCLOPHOSPHAMIDE (362)
VINCRISTINE (331)
DEXAMETHASONE (282)
METHOTREXATE (280)
METHYLPREDNISOLONE (255)
CYTARABINE (250)
MERCAPTOPURINE (241)
DAUNORUBICIN (240)
ETOPOSIDE (240)
Which PEGASPARGASE Alternatives Have Lower Secondary immunodeficiency Risk?
PEGASPARGASE vs PEGASYS
PEGASPARGASE vs PEGCETACOPLAN
PEGASPARGASE vs PEGFILGRASTIM
PEGASPARGASE vs PEGFILGRASTIM-APGF
PEGASPARGASE vs PEGFILGRASTIM-BMEZ